On Tuesday, Innodata hit an important technical milestone, with its Relative Strength (RS) Rating moving into the 90-plus percentile with an improvement to 93, an increase from 89 the day before.
Here Are 3 Keys For Successful Stock Investing
IBD's unique rating measures share price action with a 1 (worst) to 99 (best) score. The score shows how a stock's price performance over the trailing 52 weeks stacks up against all the other stocks in our database.
Decades of market research shows that the best stocks tend to have an RS Rating of at least 80 at the beginning of a new run.
The IBD 50 stock is trying to complete a cup without handle with a 55.69 buy point. See if the stock can clear the breakout price in volume at least 40% above average.
The company posted 0% EPS growth last quarter, while sales growth came in at 79%.
Innodata holds the No. 4 rank among its peers in the Computer-Technical Services industry group. TaskUs is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
